Intuitive Surgical (NASDAQ:ISRG)‘s stock had its “buy” rating reaffirmed by analysts at Goldman Sachs Group in a note issued to investors on Saturday, November 18th.
Other equities research analysts have also issued reports about the stock. Vetr lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 price target for the company. in a report on Wednesday, August 16th. Royal Bank Of Canada reissued a “hold” rating and set a $111.11 price objective on shares of Intuitive Surgical in a research report on Friday, July 21st. Citigroup reissued a “buy” rating and set a $119.78 price objective (up from $101.89) on shares of Intuitive Surgical in a research report on Monday, July 24th. Wells Fargo & Company reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Monday, October 16th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $116.67 target price on shares of Intuitive Surgical in a research report on Friday, July 21st. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Intuitive Surgical presently has an average rating of “Buy” and a consensus price target of $155.78.
Shares of Intuitive Surgical (NASDAQ ISRG) traded down $0.45 during trading hours on Friday, reaching $369.50. 1,864,309 shares of the company traded hands, compared to its average volume of 974,046. The stock has a market capitalization of $44,444.88, a PE ratio of 52.49, a P/E/G ratio of 5.51 and a beta of 0.48. Intuitive Surgical has a 12 month low of $203.57 and a 12 month high of $405.05.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.78. The business had revenue of $806.10 million during the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. Intuitive Surgical’s revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.06 earnings per share. analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current year.
In other Intuitive Surgical news, SVP Curet Myriam sold 262 shares of the stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $373.00, for a total transaction of $97,726.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Marshall Mohr sold 6,000 shares of the stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the sale, the chief financial officer now directly owns 12,316 shares of the company’s stock, valued at $4,584,261.52. The disclosure for this sale can be found here. Insiders sold a total of 55,944 shares of company stock worth $21,432,971 in the last quarter. Company insiders own 2.20% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Eqis Capital Management Inc. bought a new stake in Intuitive Surgical in the second quarter worth $326,000. APG Asset Management N.V. lifted its position in Intuitive Surgical by 4.3% in the second quarter. APG Asset Management N.V. now owns 28,482 shares of the medical equipment provider’s stock worth $26,641,000 after buying an additional 1,176 shares during the last quarter. Huntington National Bank lifted its position in Intuitive Surgical by 50.0% in the second quarter. Huntington National Bank now owns 255 shares of the medical equipment provider’s stock worth $239,000 after buying an additional 85 shares during the last quarter. First Citizens Bank & Trust Co. lifted its position in Intuitive Surgical by 88.3% in the second quarter. First Citizens Bank & Trust Co. now owns 1,049 shares of the medical equipment provider’s stock worth $981,000 after buying an additional 492 shares during the last quarter. Finally, Jag Capital Management LLC lifted its position in Intuitive Surgical by 69.6% in the second quarter. Jag Capital Management LLC now owns 14,002 shares of the medical equipment provider’s stock worth $13,097,000 after buying an additional 5,748 shares during the last quarter. 32.81% of the stock is owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical (ISRG) Stock Rating Reaffirmed by Goldman Sachs Group” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/05/intuitive-surgical-inc-isrg-stock-rating-reaffirmed-by-goldman-sachs-group-inc-the.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.